Juncture Wealth Strategies, LLC Bristol Myers Squibb CO Transaction History
Juncture Wealth Strategies, LLC
- $281 Million
- Q2 2025
A detailed history of Juncture Wealth Strategies, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Juncture Wealth Strategies, LLC holds 11,116 shares of BMY stock, worth $510,780. This represents 0.18% of its overall portfolio holdings.
Number of Shares
11,116
Previous 11,372
2.25%
Holding current value
$510,780
Previous $693,000
25.83%
% of portfolio
0.18%
Previous 0.27%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.79 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...